Cresco Labs Inc (CRLBF)
2.10
-0.08
(-3.74%)
USD |
OTCM |
May 06, 16:00
Cresco Labs Cash from Investing (Quarterly): 2.609M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.609M |
| September 30, 2023 | -12.48M |
| June 30, 2023 | -14.05M |
| March 31, 2023 | -20.67M |
| December 31, 2022 | -12.45M |
| September 30, 2022 | 23.48M |
| June 30, 2022 | -13.39M |
| March 31, 2022 | -34.22M |
| December 31, 2021 | -64.11M |
| September 30, 2021 | -43.45M |
| June 30, 2021 | -29.59M |
| March 31, 2021 | -26.79M |
| December 31, 2020 | -9.403M |
| September 30, 2020 | -25.35M |
| June 30, 2020 | 22.16M |
| March 31, 2020 | -52.15M |
| December 31, 2019 | -21.69M |
| September 30, 2019 | -33.56M |
| June 30, 2019 | -34.86M |
| March 31, 2019 | -17.48M |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | -0.075M |
| October 31, 2017 | -0.0022M |
| Date | Value |
|---|---|
| July 31, 2017 | 0.0067M |
| April 30, 2017 | 0.0705M |
| January 31, 2017 | |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | 0.00 |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.0018M |
| April 30, 2013 | -0.0018M |
| January 31, 2013 | -0.0024M |
| October 31, 2012 | -0.0101M |
| July 31, 2012 | -0.0165M |
| April 30, 2012 | -0.0224M |
| January 31, 2012 | 0.1965M |
| October 31, 2011 | 0.00 |
| July 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-64.11M
Minimum
Dec 2021
23.48M
Maximum
Sep 2022
-21.05M
Average
-21.69M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Flora Growth Corp | 0.038M |
| Tilray Brands Inc | 28.09M |
| Clever Leaves Holdings Inc | 2.056M |
| Seelos Therapeutics Inc | -- |
| Skye Bioscience Inc | -0.007M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.302M |
| Cash from Financing (Quarterly) | -3.782M |
| Free Cash Flow | 0.681M |
| Free Cash Flow Per Share (Quarterly) | -0.025 |
| Free Cash Flow to Equity (Quarterly) | 2.274M |
| Free Cash Flow to Firm (Quarterly) | -3.041M |
| Free Cash Flow Yield | 0.10% |